Bioprocessing - Upstream & Downstream

Why is the stable pools approach attracting more attention in the cell line development space?

Academia has its appeal for many; for others the real challenges are in industry. Here, IO Biotech CEO Mai-Britt Zocca discusses her own motivations.

Gene therapy approvals have come thick and fast in 2023. Now let’s talk about how we can ramp up manufacturing speed with platform processes.

mRNA therapeutics are a hot development trend, but with expertise and experience in short supply, who are the unsung heroes?

In this eBook, experts from Asahi Kasei Bioprocess discuss key areas of bioprocessing.

With mRNA technology scooping the 2023 Nobel Prize for Medicine, demand is growing. Can CDMOs keep up?

From flu vaccines, to gene editing, to antibody drug conjugates, and women’s careers; we look back on our 2023 magazine covers.

Academia suggests we need to upgrade lyophilization, but scientists are being slow to respond

The use of multimodal chromatography is increasing in biopharma purification processes. Here’s why.

Discover how Asahi Kasei Bioprocess is engineering a streamlined approach to chromatography media preparation.